Key Insights

Highlights

Success Rate

88% trial completion (above average)

Published Results

371 trials with published results (14%)

Research Maturity

1417 completed trials (52% of total)

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 40/100

Termination Rate

6.9%

187 terminated out of 2701 trials

Success Rate

88.3%

+1.8% vs benchmark

Late-Stage Pipeline

17%

454 trials in Phase 3/4

Results Transparency

26%

371 of 1417 completed with results

Key Signals

371 with results88% success187 terminated

Data Visualizations

Phase Distribution

1,654Total
Not Applicable (1048)
Early P 1 (4)
P 1 (39)
P 2 (109)
P 3 (185)
P 4 (269)

Trial Status

Completed1,417
Unknown513
Recruiting282
Terminated187
Active Not Recruiting109
Not Yet Recruiting84

Trial Success Rate

88.3%

Benchmark: 86.6%

Based on 1417 completed trials

Clinical Trials (2701)

Showing 20 of 20 trials
NCT05898165Active Not RecruitingPrimary

Future Innovations in Novel Detection for Atrial Fibrillation (FIND-AF): Pilot Study

NCT04331535Not ApplicableActive Not Recruiting

The Genomic Medicine at VA Study

NCT06184633Phase 4Active Not RecruitingPrimary

DUTCH Weight Control in Atrial Fibrillation Study

NCT07254455Not ApplicableNot Yet RecruitingPrimary

CASTLE-HFpEF (Catheter Ablation for Atrial Fibrillation Patients With Heart Failure With Mildly Reduced and Preserved Ejection Fraction)

NCT07146061Recruiting

pCAD-POAF 3 Year Follow-up

NCT04642430Phase 4RecruitingPrimary

COmparison of Bleeding Risk Between Rivaroxaban and Apixaban in Patients With Atrial Fibrillation

NCT05836987Phase 3RecruitingPrimary

The Rhythm Evaluation for AntiCoagulaTion With Continuous Monitoring of Atrial Fibrillation

NCT06580275Not ApplicableCompletedPrimary

The GLACE Study: Evaluating CLAAS With ICE Guided LAA Closure

NCT04624646Not ApplicableTerminatedPrimary

Clinical Implication of Atrial Fibrillation Detection Using Wearable Device in Patients With Cryptogenic Stroke

NCT01422148Phase 2WithdrawnPrimary

Minocycline Plus Amiodarone Versus Amiodarone Alone for the Prevention of Atrial Fibrillation After Cardiac Surgery

NCT06798714Phase 4Completed

The Effect of Colchicine on the Occurrence of Atrial Fibrillation After Cardiac Surgery

NCT07227532Not ApplicableRecruitingPrimary

A Study Assessing Long-Term Safety and Effectiveness in Treatment Management of Atrial Fibrillation With VARIPULSE Catheter System

NCT05664308RecruitingPrimary

Interest of a Hybrid Connected Watch for Cardiac Rhythm Monitoring in Post-operative Cardiac Surgery

NCT05971693Not ApplicableCompletedPrimary

A Study For Treatment of Paroxysmal Atrial Fibrillation (PAF) With the OMNYPULSE Catheter and the TRUPULSE Generator

NCT07845682Not ApplicableNot Yet RecruitingPrimary

A Study of Dual Energy THERMOCOOL SMARTTOUCH™ SF Catheter With TRUPULSE™ Generator in Persistent Atrial Fibrillation

NCT05773768Not ApplicableCompletedPrimary

EHRA-PATHS: Clinical and Health Economic Evaluation of New Care Pathways

NCT06376916Phase 3Recruiting

Comparing Magnesium 2g Versus 4g Versus Placebo in the Incidence of Treating AFF RVR

NCT07217067Phase 2RecruitingPrimary

A Study to Investigate the Efficacy, Safety, Tolerability and Pharmacokinetics of PKN605 in Participants With Atrial Fibrillation

NCT07429214Not ApplicableRecruitingPrimary

A Study of VARIPULSE Catheter and TRUPULSE Generator With VARIPULSE Pro Software in Participants With PAF or PsAF

NCT07527299Not ApplicableRecruitingPrimary

A Study of VARIPULSE Catheter in Participants With Persistent Atrial Fibrillation Undergoing Pulmonary Vein and Superior Vena Cava Isolation

Scroll to load more

Research Network

Activity Timeline